Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9655 | 1067 | 26.6 | 51% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
691 | 12372 | CERVICAL LENGTH//CERVICAL RIPENING//PRETERM LABOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | TOCOLYSIS | Author keyword | 53 | 35% | 11% | 122 |
2 | RITODRINE | Author keyword | 34 | 46% | 5% | 55 |
3 | ATOSIBAN | Author keyword | 23 | 43% | 4% | 41 |
4 | TOCOLYTICS | Author keyword | 15 | 42% | 3% | 27 |
5 | MAINTENANCE TOCOLYSIS | Author keyword | 15 | 88% | 1% | 7 |
6 | RITODRINE HYDROCHLORIDE | Author keyword | 8 | 42% | 1% | 14 |
7 | TOCOLYTIC THERAPY | Author keyword | 7 | 50% | 1% | 10 |
8 | TOCOLYTIC AGENTS THERAPEUTIC USE | Author keyword | 7 | 67% | 1% | 6 |
9 | ORAL TOCOLYSIS | Author keyword | 6 | 80% | 0% | 4 |
10 | FETO MATERNAL MED GYNECOL | Address | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TOCOLYSIS | 53 | 35% | 11% | 122 | Search TOCOLYSIS | Search TOCOLYSIS |
2 | RITODRINE | 34 | 46% | 5% | 55 | Search RITODRINE | Search RITODRINE |
3 | ATOSIBAN | 23 | 43% | 4% | 41 | Search ATOSIBAN | Search ATOSIBAN |
4 | TOCOLYTICS | 15 | 42% | 3% | 27 | Search TOCOLYTICS | Search TOCOLYTICS |
5 | MAINTENANCE TOCOLYSIS | 15 | 88% | 1% | 7 | Search MAINTENANCE+TOCOLYSIS | Search MAINTENANCE+TOCOLYSIS |
6 | RITODRINE HYDROCHLORIDE | 8 | 42% | 1% | 14 | Search RITODRINE+HYDROCHLORIDE | Search RITODRINE+HYDROCHLORIDE |
7 | TOCOLYTIC THERAPY | 7 | 50% | 1% | 10 | Search TOCOLYTIC+THERAPY | Search TOCOLYTIC+THERAPY |
8 | TOCOLYTIC AGENTS THERAPEUTIC USE | 7 | 67% | 1% | 6 | Search TOCOLYTIC+AGENTS+THERAPEUTIC+USE | Search TOCOLYTIC+AGENTS+THERAPEUTIC+USE |
9 | ORAL TOCOLYSIS | 6 | 80% | 0% | 4 | Search ORAL+TOCOLYSIS | Search ORAL+TOCOLYSIS |
10 | TOCOLYTIC AGENT | 4 | 75% | 0% | 3 | Search TOCOLYTIC+AGENT | Search TOCOLYTIC+AGENT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RITODRINE | 73 | 47% | 11% | 116 |
2 | OXYTOCIN ANTAGONIST ATOSIBAN | 37 | 59% | 4% | 41 |
3 | RITODRINE TOCOLYSIS | 26 | 100% | 1% | 11 |
4 | PREMATURE LABOR | 26 | 24% | 9% | 95 |
5 | ACUTE TOCOLYSIS | 23 | 86% | 1% | 12 |
6 | TOCOLYSIS | 21 | 27% | 6% | 69 |
7 | RITODRINE HYDROCHLORIDE | 19 | 55% | 2% | 24 |
8 | INTRAPARTUM FETAL DISTRESS | 12 | 86% | 1% | 6 |
9 | ORAL TERBUTALINE | 11 | 45% | 2% | 18 |
10 | TOCOLYTIC THERAPY | 10 | 41% | 2% | 19 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Tocolytic treatment for the management of preterm labor: A review of the evidence | 2003 | 90 | 62 | 76% |
Betamimetics for inhibiting preterm labour | 2014 | 5 | 53 | 58% |
Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour | 2010 | 8 | 7 | 86% |
Calcium Channel Blockers for the Management of Preterm Birth: A Review | 2011 | 9 | 56 | 82% |
Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipine | 2003 | 45 | 23 | 83% |
Calcium channel blockers for inhibiting preterm labour and birth | 2014 | 2 | 76 | 71% |
Tocolysis with nifedipine or beta-adrenergic agonists: A meta-analysis | 2001 | 75 | 20 | 65% |
Safety concerns for the use of calcium channel blockers in pregnancy for the treatment of spontaneous preterm labour and hypertension: a systematic review and meta-regression analysis | 2010 | 11 | 45 | 49% |
Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour | 2013 | 4 | 10 | 80% |
Calcium channel blockers for tocolysis: A review of their role and safety following reports of serious adverse events | 2006 | 24 | 49 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FETO MATERNAL MED GYNECOL | 4 | 75% | 0.3% | 3 |
2 | MED EDUC MATERNAL FETAL MED | 1 | 100% | 0.2% | 2 |
3 | OB GYN PEDIAT | 1 | 50% | 0.2% | 2 |
4 | TRANSLATING INTO PRACTICE TRIP | 1 | 100% | 0.2% | 2 |
5 | GOOD SAMARITAN MED | 1 | 40% | 0.2% | 2 |
6 | CLIN PHARM PHARMACOL GRONINGEN | 1 | 50% | 0.1% | 1 |
7 | COMM QUAL ASSURANCE | 1 | 50% | 0.1% | 1 |
8 | FEDERAT ANESTHESIE REANIMAT CHIRURG | 1 | 50% | 0.1% | 1 |
9 | GRIGORE T POPA IASI | 1 | 50% | 0.1% | 1 |
10 | GYNECOL OBSTETR UNIV HOSP | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000216553 | MAGNESIUM SULFATE//ECLAMPSIA//MAGNESIUM SULPHATE |
2 | 0.0000156534 | CERVICAL LENGTH//CERVICAL INCOMPETENCE//CERCLAGE |
3 | 0.0000138881 | PORCINE UTERUS//RL SMITH MENTAL RETARDAT//PHARMACODYNAM BIOPHARM |
4 | 0.0000109200 | CHRONIC HYPERTENSION//CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY//LABETALOL |
5 | 0.0000085920 | PATENT DUCTUS ARTERIOSUS//DUCTUS ARTERIOSUS//ORAL IBUPROFEN |
6 | 0.0000085292 | MATERNAL SEPSIS//OBSTETRIC PATIENTS//OBSTETRIC ADMISSIONS |
7 | 0.0000082671 | OXYTOCIN RECEPTOR//OXYTOCIN ANTAGONIST//BARUSIBAN |
8 | 0.0000074418 | ANTENATAL CORTICOSTEROIDS//BETAMETHASONE//ANTENATAL GLUCOCORTICOIDS |
9 | 0.0000061249 | ELECTROHYSTEROGRAPHY//ELECTROHYSTEROGRAM//PHOSPHATIDYLINOSITOL SIGNALING PATHWAY |
10 | 0.0000059005 | ORNITHINE DECARBOXYLASE IN DEVELOPING BRAIN//ADENYLYL CYCLASE SIGNALING//NORADRENERGIC SYSTEMS |